Report cover image

Pricing Strategy & Health Economics in the Era of Negotiated Rates & Value-Based Care

Publisher ResearchCubes
Published Mar 31, 2026
Length 36 Pages
SKU # RCUB21142022

Description

This executive briefing navigates Inflation Reduction Act price negotiations, health economics dossier building for payer alignment, and risk-sharing agreement structuring to protect margins while ensuring patient access. The report examines IRA impact (negotiated prices up to 80% off list), health tech integration mandates, HEOR capability requirements, and access innovation strategies. Key findings include organizations with mature health economics capabilities seeing 15-25% better pricing outcomes, value dossiers reducing negotiation cycles by 40%, and innovative pricing models (outcomes-based, tiered) enabling access in restricted markets. The report provides pricing strategists and health economics leaders with frameworks, case studies, and negotiation playbooks for 2026 and beyond.

Table of Contents

36 Pages
EXECUTIVE SUMMARY
1.1 Methodology & Pricing Landscape
1.2 IRA Impact: Negotiated Prices & Strategic Response
1.3 Key Findings: Value Dossiers, Risk-Sharing & Access Innovation
PRICING MATURITY ASSESSMENT
2.1 Four Stages: From List Price Pricing to Value-Based Negotiation
2.2 Capability Assessment: Health Economics, Payer Intelligence, Negotiation
2.3 Evidence Requirements: Clinical, Economic & Real-World Data
2.4 Peer Benchmarking (Pricing Strategy Maturity)
STRATEGIC IMPERATIVES FOR 2026
3.1 Inflation Reduction Act Compliance & Negotiation Preparation
3.2 Value Dossier Development: Clinical + Health Economics + RWE
3.3 Payer Alignment Strategy: Evidence Packages & Negotiation Tactics
3.4 Risk-Sharing Agreements: Outcomes-Based Contracts & Performance Guarantees
3.5 Access Innovation: Tiered Pricing, Patient Assistance & Global Strategies
HEALTH ECONOMICS & VALUE DEMONSTRATION
4.1 Comparative Effectiveness Research (CER) & Health Economics Models
4.2 Value Dossier Structure: What Payers Demand
4.3 Outcomes-Based Contracts: Design & Risk Mitigation
4.4 Case Study: Successful IRA Negotiation Strategy
PAYER NEGOTIATION & MARKET ACCESS
5.1 Payer Landscape & Decision-Making Frameworks
5.2 Evidence Packages & Health Technology Assessment (HTA) Preparation
5.3 Global Pricing Coordination & Exchange Rate Risk
5.4 Patient Access Programs & Financial Assistance
PRICING STRATEGY IMPLEMENTATION
6.1 Phase 1 (Months 1-3): IRA Compliance & Dossier Preparation
6.2 Phase 2 (Months 4-8): Payer Engagement & Negotiation
6.3 Phase 3 (Months 9-12): Market Launch & Performance Management
6.4 Budget & Risk Mitigation
APPENDICES
A. Pricing Maturity Self-Assessment
B. Health Economics Dossier Template
C. Risk-Sharing Agreement Framework
D. Payer Intelligence Toolkit
E. Negotiation Playbook & Objection Handling
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.